The health effects of cost-related treatment delays

American Journal of Medical Quality

Volumn 26, Issue 4, 2011, Pages 261-271

  Chen, Jie ^a   Rizzo, John A ^b   Rodriguez, Hector P ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

health care delivery; health status; treatment adherence; treatment delays

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE SURVEY; HEALTH STATUS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATIENT ATTITUDE; PATIENT COMPLIANCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; FINANCING, PERSONAL; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; UNITED STATES; YOUNG ADULT;

EID: 79960235198     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860610390352     Document Type: Article

References (36)

1. Cunningham PJ, Felland LE Falling behind: Americans' access to medical care deteriorates, 2003-2007. Community Tracking Study No. 19. 2008. http://www.hschange.org/CONTENT/993/993.pdf. Accessed July 20, 2009.
2. Rash MC Poor economy forcing people to delay health care treatment. http://triad.bizjournals.com/triad/stories/2009/04/20/focus2.html. Accessed July 20, 2009.
3. Kaiser Family Foundation. Six in ten say family put off medical care due to cost. http://www.kff.org/kaiserpolls/pomr042309nr.cfm. Accessed July 27, 2009.
4. DiMatteo MR Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
5. Vermerie E., Hearnshaw H., Van Royen P., Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331-342.
6. Chitale R. Vulnerable populations more likely to delay or forgo treatment. http://abcnews.go.com/Health/story?id=5263717&page=1. Accessed July 23, 2009.
7. Simpson SH, Eurich DT, Majumdar SR,et al.A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15-20.
8. Wang PS, Berglund P., Olfson M., Pinchus HA, Wells KB, Kessler RC Failure and delay in initial treatment contact after first onset of mental disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:603-613.
9. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
10. McCombs JS, Thiebaud P., McLaughlin-Miley C., Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas. 2004;48:271-287.
11. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43:517-520.
12. Agency for Healthcare Research and Quality, Center for Financing, Access and Cost Trends. MEPS HC-105: 2006 full year consolidated data file. http://www.meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h105/h105doc.pdf. Accessed June 29, 2009.
13. Baker DW, Hays RD, Brook RH Understanding changes in health status: is the floor phenomenon merely the last step of the staircase? Med Care. 1997;35:1-15.
14. Stockdale S., Lagomasino I., Siddique J., McGuire T., Miranda J. Ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995-2003. Med Care. 2008;46:668-677.
15. Lichtenberg F. Pharmaceutical embodied technical progress, longevity, and quality of life: drugs as "equipment for your health." http://www.nber.org/papers/w9351. Accessed October 16, 2010.
16. Grossman M. The human capital model. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Vol 1A (pp 347-408). Amsterdam, Netherlands: Elsevier; 2000.
17. Wagstaff A. The economic consequences of health shocks: evidence from Vietnam. J Health Econ. 2007;26:82-100.
18. Zuvekas SH, Fleishman JA Self-rated mental health and racial/ethnic disparities in mental health service use. Med Care. 2008;46:915-923.
19. Ware JE, Kosinski M., Keller SD A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220.
20. Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J., Osher FC Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000; 38:1141-1150.
21. Cheak-Zamora NC, Wyrwich KW, McBride TD Reliability and validity of the SF-12v2 in the Medical Expenditure Panel Survey. Qual Life Res. 2009;18:727-735.
22. Flores G. Language barriers to health care in the United States. N Engl J Med. 2006;355:229-231.
23. Ku L. Health insurance coverage and medical expenditures of immigrants and native-born citizens in the United States. Am J Public Health. 2009;99:1322-1328.
24. Kerr E., Heisler M., Krein S.,et al.Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med. 2007;22:1635-1640.
25. Blinder AS Wage discrimination: reduced from and structural estimates. J Hum Resour. 1973;8:436-455.
26. Oaxaca R. Male-female wage differentials in urban labor markets. J Econ Rev. 1973;14:693-709.
27. Jann B. The Blinder-Oaxaca decomposition for linear regression models. Stata J. 2008;8:453-479.
28. Vargas Bustamante A., Fang H., Rizzo JA, Ortega AN Understanding observed and unobserved health care access and utilization disparities among US Latino adults. Med Care Res Rev. 2009;66:561-577.
29. Fairlie R. An extension of the Blinder-Oaxaca decomposition technique to logit and probit models. J Econ Soc Meas. 2005;10:305-316.
30. Santerre RE, Neun SP Health Economics: Theory, Insights, and Industry Studies. Mason, OH: South-Western College Publishing; 2009.
31. Catlin A., Cowan C., Hartman M., Heffler S.; National Health Expenditure Accounts Team. National health spending in 2006: a year of change for prescription drugs. Health Aff (Millwood). 2008;27:14-29.
32. Paez KA, Zhao L., Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Health Aff (Millwood). 2009;28:15-25.
33. Pisinger C., Ladelund S., Glumer C., Toft U., Aadahl M., Jørgensen T. Five years of lifestyle intervention improved self-reported mental and physical health in a general population: the Inter99 study. Prev Med. 2009;49:424-428.
34. Pisinger C., Toft U., Aadahl M., Glümer C., Jørgensen T. The relationship between lifestyle and self-reported health in a general population: the Inter99 study. Prev Med. 2009;49:418-423.
35. Molarius A., Janson S. Self-rated health, chronic diseases, and symptoms among middle-aged and elderly men and women. J Clin Epidemiol. 2002;55:364-370.
36. Bailis DS, Segall A., Chipperfield JG Two views of self-rated general health status. Soc Sci Med. 2003;56:203-217.